Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NRIX), sold 7,520 shares at $18.42 ($139K) on 2026-01-20, disclosed to the SEC on 2026-01-20.
Open-market sale of $139k NRIX by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.42 | 3,760 | $69K | 50.0% |
| 2 | $18.42 | 3,760 | $69K | 50.0% |
| Total | $18.42 avg | 7,520 | $139K | 100% |
| Filing → |
| NRIX | SELL | 2026-08-03 | $382K | — | Filing → |
| NRIX | SELL | 2026-07-30 | $90K | — | Filing → |
| NRIX | SELL | 2026-07-02 | $259K | — | Filing → |